NCT06359860
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Peking University Cancer Hospital & Institute Beijing, China
Clinical trial condition
Unresectable or Metastatic Melanoma
Explore clinical trials studying Unresectable or Metastatic Melanoma. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Unresectable or Metastatic Melanoma trial results
Not Yet Recruiting
PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma
NCT07700121
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01844505
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Local Institution - 0085 Gilbert, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- Local Institution - 0046 La Jolla, California, United States
- Local Institution - 0053 Los Angeles, California, United States
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- UCSD Moores Cancer Center La Jolla, California, United States
- The Angeles Clinic & Research Institute Los Angeles, California, United States
- University Of California - Los Angeles Los Angeles, California, United States
Active, Not Recruiting
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
NCT04674683
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
- Locations
-
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Innovative Clinical Research Institute (ICRI) Pasadena, California, United States
- Emad Ibrahim, MD, INC Redlands, California, United States